Lexicon Pharmaceuticals (LXRX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.32 --0%
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $355 thousand versus the consensus estimate of $320 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
